Regional blood centers

New York Blood Center (NYBC) is one of the largest independent, community-based blood centers in the world, serving as a major hub for both blood services and life sciences research. Beyond its role in blood collection and distribution, NYBC operates the Lindsley F. Kimball Research Institute, which has pioneered significant medical breakthroughs including the development of the Hepatitis B vaccine and solvent/detergent viral inactivation technology. The organization is also notable for developing HEMACORD, the first FDA-licensed hematopoietic stem cell product derived from umbilical cord blood. NYBC continues to advance a pipeline of cell therapies, vaccines for emerging infectious diseases, and specialized blood products to treat conditions like sickle cell disease and various cancers. Its business model combines non-profit healthcare services with a robust portfolio of intellectual property and commercialized medical technologies.